Cell TypePrimary Sensory Neurons
[^1]
LocationDorsal Root Ganglia (DRG)
[^2]
FunctionSensory transduction
[^3]
ClassificationPseudounipolar neurons
Dorsal root ganglion (DRG) neurons are primary sensory neurons whose cell bodies reside in the peripheral nervous system within the dorsal root ganglia. These neurons are essential for transmitting sensory information from peripheral receptors to the central nervous system. In neurodegenerative and metabolic conditions, DRG neurons undergo degeneration, leading to peripheral neuropathy characterized by sensory deficits, pain, and autonomic dysfunction 1.
| Taxonomy |
ID |
Name / Label |
| Cell Ontology (CL) |
CL:2000032 |
peripheral nervous system neuron |
- Morphology: peripheral nervous system neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
¶ Anatomy and Morphology
DRG neurons are pseudounipolar neurons with:
- Cell body (soma): Located within the ganglion, containing the nucleus and cytoplasmic organelles
- Peripheral axon: Extends to peripheral targets (skin, muscle, viscera)
- Central axon: Projects into the dorsal horn of the spinal cord
DRG neurons are classified by axonal diameter and myelination 2:
| Type |
Diameter |
Myelination |
Function |
| Aβ |
>6 μm |
Heavy (myelinated) |
Touch, pressure, vibration |
| Aδ |
1-6 μm |
Light (myelinated) |
Pain (fast), temperature |
| C |
<1 μm |
Unmyelinated |
Pain (slow), itch, warmth |
DRG neurons express diverse ion channels mediating sensory transduction 3:
- Voltage-gated sodium channels: Nav1.7, Nav1.8, Nav1.9 (pain signaling)
- Transient receptor potential (TRP) channels: TRPV1 (capsaicin/heat), TRPA1 (irritants/cold)
- Voltage-gated calcium channels: N-type (Cav2.2), T-type (Cav3.2)
- Potassium channels: Kv1.1, Kv1.2, TREK1 (resting membrane potential)
- TrkA: Nerve growth factor (NGF) - small nociceptors
- TrkB: Brain-derived neurotrophic factor (BDNF) - mechanoreceptors
- TrkC: Neurotrophin-3 (NT-3) - proprioceptors
- p75NTR: Pan-neurotrophin receptor (apoptosis signaling)
DRG neurons convert physical and chemical stimuli into electrical signals:
- Mechanoreception: Aβ neurons detect touch, pressure, vibration via mechanically-gated ion channels
- Nociception: Aδ and C fibers detect noxious stimuli via TRP channels and voltage-gated sodium channels
- Thermoreception: Warmth (TRPV3/4) and cold (TRPM8, TRPA1) detection
- Proprioception: Muscle spindle afferents (Aβ) convey position sense
Peripheral stimuli activate DRG neuron terminals, generating action potentials that travel centrally to dorsal horn neurons for processing and reflex coordination.
DRG neurons are particularly vulnerable to diabetic metabolic dysfunction 1:
- Hyperglycemia: Activates polyol pathway, increases oxidative stress
- Microvascular damage: Impairs endoneurial blood flow, causes hypoxia
- Advanced glycation end products (AGEs): Modify neuronal proteins, disrupt function
- Mitochondrial dysfunction: Reduces ATP production, compromises viability
Neurotoxic chemotherapy agents target DRG neurons 2:
- Platinum agents (oxaliplatin, cisplatin): Form DNA cross-links, cause sensory neuron death
- Taxanes (paclitaxel): Disrupt microtubules, impair axonal transport
- Vincristine: Inhibits microtubule polymerization, causes axonal degeneration
- Bortezomib: Proteasome inhibitor, induces ER stress
Immune-mediated injury to DRG neurons 3:
- Guillain-Barré syndrome: Autoantibodies against peripheral nerve antigens
- Chronic inflammatory demyelinating polyneuropathy (CIDP): T-cell mediated demyelination
- Sjögren's syndrome: Anti-Ro/La antibodies target sensory neurons
- Charcot-Marie-Tooth disease (CMT): Mutations in myelin genes (PMP22, MPZ, PO)
- Familial amyloid polyneuropathy: Transthyretin (TTR) deposition
- HSANs (Hereditary Sensory and Autonomic Neuropathies): SCN9A/11A sodium channel mutations
Excessive glutamate release leads to:
- NMDA receptor overactivation
- Calcium influx
- Activation of apoptotic pathways
- Mitochondrial dysfunction
- Reactive oxygen species (ROS) accumulation
- Impaired antioxidant defenses (glutathione, SOD)
- DNA damage
- Lipid peroxidation
- Disruption of microtubule function
- Impaired delivery of organelles and proteins
- Accumulation of damaged proteins
- Energy depletion at distal terminals
- Activation of caspases-3, -9
- Cytochrome c release from mitochondria
- BCL-2 family regulation
- p53-mediated cell death
- NGF: Clinical trials for diabetic neuropathy
- BDNF: Neuroprotective effects in preclinical models
- GDNF: Promotes DRG neuron survival
- Lidocaine: Local anesthetic, blocks Nav1.7/1.8/1.9
- Mexiletine: Oral sodium channel blocker
- CR845: Selective Nav1.8 blocker
- Alpha-lipoic acid: Antioxidant, improves mitochondrial function
- Coenzyme Q10: Electron transport chain support
- Acetyl-L-carnitine: Mitochondrial energy metabolism
- Gene therapy: AAV-mediated BDNF delivery
- Stem cell transplantation: Mesenchymal stem cells
- Calpain inhibitors: Prevent cytoskeletal degradation